A missing voice at the ethical table: The role of pharmacists on institutional ethics committees

Clicks: 15
ID: 327892
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #190 of 247 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 247 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Institutional ethics committees (IECs) are designed to support complex clinical and organizational decision making through interdisciplinary collaboration. Despite the central role of medications in many ethically challenging scenarios, pharmacists are often absent from formal IEC membership. This omission represents a structural gap in ethical deliberation within many modern health systems. Pharmacists routinely navigate decisions involving medication safety, access, cost, allocation, and appropriateness across both inpatient and outpatient settings, many of which carry significant ethical implications. Their training uniquely positions them at the intersection of clinical care, operational feasibility, and system-level stewardship. As healthcare complexity continues to increase, driven by rising drug costs, supply chain instability, and the expansion of high-cost and advanced therapies, medication-related ethical challenges are becoming more prominent. Pharmacists bring a clinical, operational, and patient-focused perspective that enhances the practicality and implementation of ethical recommendations, particularly in areas such as end-of-life care, drug shortage management, and transitions of care. Their involvement can help ensure that ethical decisions are not only theoretically sound but also feasible across the continuum of care. This commentary argues for the intentional inclusion of pharmacists on IECs and highlights their potential contributions to ethical deliberation, policy development, and case consultation. It also emphasizes the importance of engagement from both health systems and pharmacy professionals to close this gap. Expanding pharmacy representation on IECs aligns with national guidance on interdisciplinary ethics consultation and reflects the evolving role of pharmacists as integral contributors to patient care and health system leadership.
Reference Key
openalex_W7211907082 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jared C. Sheneman, Jeffrey S. Farroni
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag268
URL
https://doi.org/10.1093/ajhp/zxag268
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.